William J. Regan - Net Worth and Insider Trading
William J. Regan Net Worth
The estimated net worth of William J. Regan is at least $9 dollars as of 2024-11-13. William J. Regan is the SVP & CCO of Navidea Biopharmaceuticals Inc and owns about 8,649 shares of Navidea Biopharmaceuticals Inc (NAVB) stock worth over $9. Details can be seen in William J. Regan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that William J. Regan has not made any transactions after 2017-06-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of William J. Regan
William J. Regan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William J. Regan owns 1 companies in total, including Navidea Biopharmaceuticals Inc (NAVB) .
Click here to see the complete history of William J. Regan’s form 4 insider trades.
Insider Ownership Summary of William J. Regan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2017-06-29 | SVP-Global Regulatory Strategy |
William J. Regan Latest Holdings Summary
William J. Regan currently owns a total of 1 stock. William J. Regan owns 8,649 shares of Navidea Biopharmaceuticals Inc (NAVB) as of June 29, 2017, with a value of $9.
Latest Holdings of William J. Regan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NAVB | Navidea Biopharmaceuticals Inc | 2017-06-29 | 8,649 | 0.00 | 9 |
Holding Weightings of William J. Regan
William J. Regan Form 4 Trading Tracker
According to the SEC Form 4 filings, William J. Regan has made a total of 0 transactions in Navidea Biopharmaceuticals Inc (NAVB) over the past 5 years. The most-recent trade in Navidea Biopharmaceuticals Inc is the acquisition of 1,000 shares on June 29, 2017, which cost William J. Regan around $10,600.
Insider Trading History of William J. Regan
- 1
William J. Regan Trading Performance
GuruFocus tracks the stock performance after each of William J. Regan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William J. Regan is -12.66%. GuruFocus also compares William J. Regan's trading performance to market benchmark return within the same time period. The performance of stocks bought by William J. Regan within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William J. Regan's insider trading performs compared to the benchmark.
Performance of William J. Regan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.51 | | | | | |
| Relative Return to S&P 500(%) | 2.37 | | | | | |
William J. Regan Ownership Network
Ownership Network List of William J. Regan
Ownership Network Relation of William J. Regan
William J. Regan Owned Company Details
What does Navidea Biopharmaceuticals Inc do?
Who are the key executives at Navidea Biopharmaceuticals Inc?
William J. Regan is the SVP-Global Regulatory Strategy of Navidea Biopharmaceuticals Inc. Other key executives at Navidea Biopharmaceuticals Inc include Chief Financial Officer Craig Dais , director & 10 percent owner Scott John K Jr. , and Chief Regulatory Officer Michel Mikhail .
Navidea Biopharmaceuticals Inc (NAVB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Navidea Biopharmaceuticals Inc (NAVB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Navidea Biopharmaceuticals Inc (NAVB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Navidea Biopharmaceuticals Inc (NAVB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Navidea Biopharmaceuticals Inc Insider Transactions
William J. Regan Mailing Address
Above is the net worth, insider trading, and ownership report for William J. Regan. You might contact William J. Regan via mailing address: Navidea Biopharmaceuticals, Inc., 425 Metro Place North - Suite 450, Dublin Oh 43017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
